메뉴 건너뛰기




Volumn 15, Issue 1, 2014, Pages 50-56

Total and unbound darunavir pharmacokinetics in pregnant women infected with HIV-1: Results of a study of darunavir/ritonavir 600/100mg administered twice daily

Author keywords

Darunavir; HIV; Pharmacokinetics; Pregnancy; Ritonavir

Indexed keywords

CARBON 14; DARUNAVIR; RITONAVIR; VIRUS RNA;

EID: 84888863487     PISSN: 14642662     EISSN: 14681293     Source Type: Journal    
DOI: 10.1111/hiv.12047     Document Type: Article
Times cited : (46)

References (20)
  • 1
    • 84922439746 scopus 로고    scopus 로고
    • Pharmacokinetics of darunavir once or twice daily during and after pregnancy
    • 3rd International Workshop on HIV Pediatrics. Rome, Italy, July 15-16, 2011. Poster
    • Capparelli EV, Best BM, Stek A etal. Pharmacokinetics of darunavir once or twice daily during and after pregnancy. 3rd International Workshop on HIV Pediatrics. Rome, Italy, July 15-16, 2011. Poster P72.
    • Capparelli, E.V.1    Best, B.M.2    Stek, A.3
  • 2
    • 59849126824 scopus 로고    scopus 로고
    • Successful use of darunavir, etravirine, enfuvirtide and tenofovir/emtricitabine in pregnant woman with multiclass HIV resistance
    • Furco A, Gosrani B, Nicholas S etal. Successful use of darunavir, etravirine, enfuvirtide and tenofovir/emtricitabine in pregnant woman with multiclass HIV resistance. AIDS 2009; 23: 434-435.
    • (2009) AIDS , vol.23 , pp. 434-435
    • Furco, A.1    Gosrani, B.2    Nicholas, S.3
  • 3
    • 77950959953 scopus 로고    scopus 로고
    • Use of darunavir/ritonavir once daily in treatment-naive pregnant woman: pharmacokinetics, compartmental exposure, efficacy and safety
    • Ivanovic J, Bellagamba R, Nicastri E etal. Use of darunavir/ritonavir once daily in treatment-naive pregnant woman: pharmacokinetics, compartmental exposure, efficacy and safety. AIDS 2010; 24: 1083-1084.
    • (2010) AIDS , vol.24 , pp. 1083-1084
    • Ivanovic, J.1    Bellagamba, R.2    Nicastri, E.3
  • 4
    • 77956791964 scopus 로고    scopus 로고
    • Use of newer antiretroviral agents, darunavir and etravirine with or without raltegravir, in pregnancy: a report of two cases
    • Jaworsky D, Thompson C, Yudin MH etal. Use of newer antiretroviral agents, darunavir and etravirine with or without raltegravir, in pregnancy: a report of two cases. Antivir Ther 2010; 15: 677-680.
    • (2010) Antivir Ther , vol.15 , pp. 677-680
    • Jaworsky, D.1    Thompson, C.2    Yudin, M.H.3
  • 5
    • 70249088746 scopus 로고    scopus 로고
    • Efficacy of darunavir despite low plasma trough levels during late pregnancy in an HIV-hepatitis C virus-infected patient
    • Pacanowski J, Bollens D, Poirier JM etal. Efficacy of darunavir despite low plasma trough levels during late pregnancy in an HIV-hepatitis C virus-infected patient. AIDS 2009; 23: 1923-1924.
    • (2009) AIDS , vol.23 , pp. 1923-1924
    • Pacanowski, J.1    Bollens, D.2    Poirier, J.M.3
  • 6
    • 77949384065 scopus 로고    scopus 로고
    • Decreased plasma levels of darunavir/ritonavir in a vertically infected pregnant woman carrying multiclass-resistant HIV type-1
    • Pinnetti C, Tamburrini E, Ragazzoni E, De Luca A, Navarra P. Decreased plasma levels of darunavir/ritonavir in a vertically infected pregnant woman carrying multiclass-resistant HIV type-1. Antivir Ther 2010; 15: 127-129.
    • (2010) Antivir Ther , vol.15 , pp. 127-129
    • Pinnetti, C.1    Tamburrini, E.2    Ragazzoni, E.3    De Luca, A.4    Navarra, P.5
  • 8
    • 57349083100 scopus 로고    scopus 로고
    • Use of darunavir and enfuvirtide in a pregnant woman
    • Sued O, Lattner J, Gun A etal. Use of darunavir and enfuvirtide in a pregnant woman. Int J STD AIDS 2008; 19: 866-867.
    • (2008) Int J STD AIDS , vol.19 , pp. 866-867
    • Sued, O.1    Lattner, J.2    Gun, A.3
  • 9
    • 84888876556 scopus 로고    scopus 로고
    • A comparison of the pharmacokinetics of darunavir, atazanavir and ritonavir during pregnancy and post-partum
    • 19th Conference on Retroviruses and Opportunistic Infections. Seattle, WA, USA, March, 2012 [Poster 1013].
    • Colbers A, Moltó J, Ivanovic J etal. A comparison of the pharmacokinetics of darunavir, atazanavir and ritonavir during pregnancy and post-partum. 19th Conference on Retroviruses and Opportunistic Infections. Seattle, WA, USA, March, 2012 [Poster 1013].
    • Colbers, A.1    Moltó, J.2    Ivanovic, J.3
  • 10
    • 25144516296 scopus 로고    scopus 로고
    • Pregnancy-induced changes in pharmacokinetics: a mechanistic-based approach
    • Anderson GD. Pregnancy-induced changes in pharmacokinetics: a mechanistic-based approach. Clin Pharmacokinet 2005; 44: 989-1008.
    • (2005) Clin Pharmacokinet , vol.44 , pp. 989-1008
    • Anderson, G.D.1
  • 11
    • 9144268274 scopus 로고    scopus 로고
    • Pharmacokinetics of saquinavir plus low-dose ritonavir in human immunodeficiency virus-infected pregnant women
    • Acosta EP, Bardeguez A, Zorrilla CD etal. Pharmacokinetics of saquinavir plus low-dose ritonavir in human immunodeficiency virus-infected pregnant women. Antimicrob Agents Chemother 2004; 48: 430-436.
    • (2004) Antimicrob Agents Chemother , vol.48 , pp. 430-436
    • Acosta, E.P.1    Bardeguez, A.2    Zorrilla, C.D.3
  • 12
    • 33748911183 scopus 로고    scopus 로고
    • Reduced lopinavir exposure during pregnancy
    • Stek AM, Mirochnick M, Capparelli E etal. Reduced lopinavir exposure during pregnancy. AIDS 2006; 20: 1931-1939.
    • (2006) AIDS , vol.20 , pp. 1931-1939
    • Stek, A.M.1    Mirochnick, M.2    Capparelli, E.3
  • 13
    • 34547780413 scopus 로고    scopus 로고
    • Pharmacokinetics of darunavir/ritonavir and TMC125 alone and coadministered in HIV-negative volunteers
    • Scholler-Gyure M, Kakuda TN, Sekar V etal. Pharmacokinetics of darunavir/ritonavir and TMC125 alone and coadministered in HIV-negative volunteers. Antivir Ther 2007; 12: 789-796.
    • (2007) Antivir Ther , vol.12 , pp. 789-796
    • Scholler-Gyure, M.1    Kakuda, T.N.2    Sekar, V.3
  • 14
    • 0025139714 scopus 로고
    • Plasma protein binding of drugs in pregnancy and in neonates
    • Notarianni LJ. Plasma protein binding of drugs in pregnancy and in neonates. Clin Pharmacokinet 1990; 18: 20-36.
    • (1990) Clin Pharmacokinet , vol.18 , pp. 20-36
    • Notarianni, L.J.1
  • 15
    • 77956565656 scopus 로고    scopus 로고
    • Longitudinal study of CD4+ cell counts in HIV-negative pregnant patients
    • Towers CV, Rumney PJ, Ghamsary MG. Longitudinal study of CD4+ cell counts in HIV-negative pregnant patients. J Matern Fetal Neonatal Med 2010; 23: 1091-1096.
    • (2010) J Matern Fetal Neonatal Med , vol.23 , pp. 1091-1096
    • Towers, C.V.1    Rumney, P.J.2    Ghamsary, M.G.3
  • 16
    • 84876412798 scopus 로고    scopus 로고
    • Steady-state pharmacokinetics, cord blood concentrations, and safety of ritonavir-boosted fosamprenavir in pregnancy
    • doi:10.1097/QAI.0b013e318285 [Epub ahead of print].
    • Cespedes MS, Castor D, Ford SL etal. Steady-state pharmacokinetics, cord blood concentrations, and safety of ritonavir-boosted fosamprenavir in pregnancy. J Acquir Immune Defic Syndr 2013; doi:10.1097/QAI.0b013e318285 [Epub ahead of print].
    • (2013) J Acquir Immune Defic Syndr
    • Cespedes, M.S.1    Castor, D.2    Ford, S.L.3
  • 17
    • 80053383846 scopus 로고    scopus 로고
    • Safety and exposure of once-daily ritonavir-boosted atazanavir in HIV-infected pregnant women
    • Conradie F, Zorrilla C, Josipovic D etal. Safety and exposure of once-daily ritonavir-boosted atazanavir in HIV-infected pregnant women. HIV Med 2011; 12: 570-579.
    • (2011) HIV Med , vol.12 , pp. 570-579
    • Conradie, F.1    Zorrilla, C.2    Josipovic, D.3
  • 18
    • 79953052608 scopus 로고    scopus 로고
    • Atazanavir pharmacokinetics with and without tenofovir during pregnancy
    • Mirochnick M, Best BM, Stek AM etal. Atazanavir pharmacokinetics with and without tenofovir during pregnancy. J Acquir Immune Defic Syndr 2011; 56: 412-419.
    • (2011) J Acquir Immune Defic Syndr , vol.56 , pp. 412-419
    • Mirochnick, M.1    Best, B.M.2    Stek, A.M.3
  • 19
    • 84876296360 scopus 로고    scopus 로고
    • Protein binding of lopinavir and ritonavir during four phases of pregnancy: implications for treatment guidelines
    • Patterson KB, Dumond JB, Prince HA etal. Protein binding of lopinavir and ritonavir during four phases of pregnancy: implications for treatment guidelines. J Acquir Immune Defic Syndr 2013; 63: 51-58.
    • (2013) J Acquir Immune Defic Syndr , vol.63 , pp. 51-58
    • Patterson, K.B.1    Dumond, J.B.2    Prince, H.A.3
  • 20
    • 34347329093 scopus 로고    scopus 로고
    • Efficacy and safety of darunavir-ritonavir compared with that of lopinavir-ritonavir at 48 weeks in treatment-experienced, HIV-infected patients in TITAN: a randomised controlled phase III trial
    • Madruga JV, Berger D, McMurchie M etal. Efficacy and safety of darunavir-ritonavir compared with that of lopinavir-ritonavir at 48 weeks in treatment-experienced, HIV-infected patients in TITAN: a randomised controlled phase III trial. Lancet 2007; 370: 49-58.
    • (2007) Lancet , vol.370 , pp. 49-58
    • Madruga, J.V.1    Berger, D.2    McMurchie, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.